Exclusive breastfeeding at 6 months · women with a pre‐pregnancy BMI > 29 kg/m², who were intending to breastfeed, had no history of breast surgery, who were at least 19 years…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Non‐initiation of breastfeeding · pregnant or lactating women who were overweight or obese
It is very uncertain whether multiple methods of breastfeeding support (including social,… changes non‐initiation of breastfeeding compared with usual care (very low certainty).
1 finding from 1 review
Exclusive breastfeeding at 4‐6 weeks · pregnant or lactating women who were overweight or obese
It is very uncertain whether multiple methods of breastfeeding support (including social,… changes exclusive breastfeeding at 4‐6 weeks compared with usual care (very low certainty).
1 finding from 1 review
Exclusive breastfeeding at 6 months · pregnant or lactating women who were overweight or obese
It is very uncertain whether multiple methods of breastfeeding support (including social,… changes exclusive breastfeeding at 6 months compared with usual care (very low certainty).
1 finding from 1 review
Intervention not reported
Relapse/recurrence (end of intervention) · people with persistent depressive disorder
The intervention probably leads to lower relapse/recurrence (end of intervention) (moderate certainty).
1 finding from 1 review
Intervention not reported
Dropout due to any reason (end of intervention) · people with persistent depressive disorder
The intervention showed no clear difference in dropout due to any reason (end of intervention) (low certainty).
1 finding from 1 review
Benzodiazepine withdrawal symptoms, end of intervention · adults who withdraw from chronic benzodiazepine use
1 finding from 1 review
Benzodiazepine withdrawal symptoms, longest · adults who withdraw from chronic benzodiazepine use
1 finding from 1 review
Benzodiazepine withdrawal symptoms, end of intervention · adults who withdraw from chronic benzodiazepine use
1 finding from 1 review
Benzodiazepine withdrawal symptoms, longest · adults who withdraw from chronic benzodiazepine use
1 finding from 1 review
Benzodiazepine withdrawal symptoms, end of intervention · adults who withdraw from chronic benzodiazepine use
1 finding from 1 review
Benzodiazepine withdrawal symptoms, longest · adults who withdraw from chronic benzodiazepine use
1 finding from 1 review
Benzodiazepine withdrawal symptoms, end of intervention · adults who withdraw from chronic benzodiazepine use
1 finding from 1 review
Benzodiazepine withdrawal symptoms, longest · adults who withdraw from chronic benzodiazepine use
1 finding from 1 review
Benzodiazepine withdrawal symptoms, end of intervention · adults who withdraw from chronic benzodiazepine use
1 finding from 1 review
Benzodiazepine withdrawal symptoms, longest · adults who withdraw from chronic benzodiazepine use
1 finding from 1 review
Benzodiazepine withdrawal symptoms, end of intervention · adults who withdraw from chronic benzodiazepine use
1 finding from 1 review
Withdrawal syndrome (clinical diagnosis), end of intervention · adults who withdraw from chronic benzodiazepine use
Alpidem may leads to higher withdrawal syndrome (clinical diagnosis), end of intervention compared with placebo (low certainty).
1 finding from 1 review
Benzodiazepine withdrawal symptoms, longest · adults who withdraw from chronic benzodiazepine use
1 finding from 1 review
Benzodiazepine withdrawal symptoms, end of intervention · adults who withdraw from chronic benzodiazepine use
1 finding from 1 review